Аnalysis of risk factors in patients with multiple sclerosis in terms of comorbidity
ARTICLE PDF (Українська)

How to Cite

Chupryna, G., Svyrydova, N., & Galusha, A. (2016). Аnalysis of risk factors in patients with multiple sclerosis in terms of comorbidity. East European Journal of Neurology, (5(11), 12-16. https://doi.org/10.33444/2411-5797.2016.5(11).12-16

Abstract

Were analyzed risk factors (RF) in patients with multiple sclerosis (MS) in the aspect of comorbidity. It was systematized and analyzed anamnestic RF and the development of MS. It is shown that multifactorial pathological effects is most important as a factor of development of the disease, exacerbation and progression in MS. Along with such traditional RF of MS, as a viral infection, psycho-emotional stress, and childbirth, the development of disease exacerbation and progression in MS also have an important role such RF as sleep disturbances, exacerbation of visceral disease and exacerbation of pain.

https://doi.org/10.33444/2411-5797.2016.5(11).12-16
ARTICLE PDF (Українська)

References

1. Мурашко Н.К. Аналіз коморбідності та чинників стилю життя у хворих з розсіяним склерозом // Мурашко Н.К. ,Чуприна Г.М.// Сімейна медицина .– 2013. - № 5.- С.85-88
2. Оринчак Л.Б. Розсіяний склероз і вітамін D / Оринчак Л.Б. // Укр. неврол. журн.— 2013.— № 2.— С. 28—33.
3.Чуприна Г.М. Розсіяний склероз: етіологія, епідеміологія, окремі питання патогенезу / Чуприна Г.М.// Лік. справа- Врач. дело.- 2012.-№6.- С. 129- 134.
4.Чуприна Г.М. Розсіяний склероз і цукровий діабет: коморбідність, спільні аспекти епідеміології, етіології та фактори ризику / Чуприна Г.М. //Ліки України .- 2015.-№5.- С.9-14.
5. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis / D’hooghea M. B., Haentjensb P., Nagelsa G. [et al.] // Europ J of Neur. - 2012. - Vol. 19. – Р.616–624.
6. Ascherio A. Environmental risk factors for multiple sclerosis. Part I: the role of infection / Ascherio A., Munger K.L. // Ann Neurol. – 2007. - Vol. 61. – Р. 288 – 299.
7. Role of return migration in the emergence of multiple sclerosis in the French West Indies / Cabre P.,Signate A., Olindo S., et al. //Brain, 2005; 128.-P.899-910
8. Comorbidities at multiple sclerosis diagnosis / Fromont A., Binquet C., Rollot F. [et al.] // J Neurol. - 2013. - Vol. 260. – Р. 2629–2637.
9. Dyment D.A. Genetics of multiple sclerosis/ Dyment D.A., Ebers G.C., Sadovnick A.D. //Lancet Neurology 2004; 3.- P.104-110.
10. Giovannoni G. Multiple sclerosis: the environment and causation/ Giovannoni G., Ebers G.C. // Curr Opin Neurol, 2007; 20: P. 261-268.
11. Higher relative risk for multiple sclerosis in a рediatric and adolescent diabetic population: analysis from DPV database / Bechtold S., Blaschek A., Raile K. [et al.] // Diabetes Care. – 2014. - Vol. 37,- №1. – Р.96 -101.
12. Hyoty H. Environmental causes: viral causes / Hyoty H. // Endocrinol Metab Clin North Am. – 2004. - Vol. 33. – Р. 27–44.
13. Kang J.H. Comorbidities amongst patients with multiple sclerosis: A population-based controlled study / Kang J.H., Chen Y.H., Lin H.C. // Eur J Neurol. – 2010. – Vol. 17. – P. 1215–1219.
14. Meta-analysis of the relationship between multiple sclerosis and migraine / Pakpoor J., Handel A. E., Giovannoni G. [et al.] // Plos One.- 2012.- Vol. 7. - Issue 9. - e45295. - Р. 1 – 6.
15. Multiple sclerosis: risk factors, prodromes, and potential causal pathways / Sreeram V., Ramagopalan S.V., Dobson R. [et al.] // Lancet Neurol. -2010. - Vol. 9. - Р. 727–739.
16. Risk of arterial cardiovascular diseases in patients with multiple sclerosis: A population-based cohort study / Christiansen C.F., Christensen S., Farkas D.K. [et al.] / Neuroepidemiology. – 2010. – Vol. 35.- P. 267–274.
17. The risk of fracture in patients with multiple sclerosis:the uk general practice research database / M.T. Bazelier , van Staa T., Uitdehaag B.M.J. [et al.] // Journal of Bone and Mineral Research. – 2011. – Vol.26. - № 9. – Р. 2271–2279.